Immuneering
IMRX
IMRX
42 hedge funds and large institutions have $9.32M invested in Immuneering in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $10.9M → $9.32M (-$1.55M)
Holders
42
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$390K | |
| 2 | +$71.1K | |
| 3 | +$49.3K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$47.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$46.1K |
Top Sellers
| 1 | -$473K | |
| 2 | -$315K | |
| 3 | -$94.6K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$36.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$29.5K |